Biotika a.s. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotika a.s. with three other
pharmaceutical manufacturers in Europe:
sales of 20.72 million Danish Kroner [US$3.38 million]
N4 Pharma PLC
of the United Kingdom
(£1.16 million [US$1.58 million]
Amryt Pharma PLC
based in the United Kingdom
(£1.11 million [US$1.52 million]
of which 100%
was Cosmetic Products).
During the year ended December of 2016, sales at
Biotika a.s. were 1.92 million Slovak Koruny (US$2.32 million).
a very small
increase of 1.2%
versus 2015, when the company's sales were 1.89 million Slovak Koruny.
This was the third consecutive year of growth at Biotika a.s..
Sales of Services saw an increase
that was more than double the company's growth rate: sales were up
9.2% in 2016, from
1.73 million Slovak Koruny to 1.88 million Slovak Koruny.
Not all segments of Biotika a.s. experienced an increase in sales in 2016:
sales of Substances fell 42.5% to 19.25 million Slovak Koruny.